Gilmore Neil O'Neill's Net Worth
$5.2 Million
Who is Gilmore Neil O'Neill?
Gilmore Neil O'Neill has an estimated net worth of $5.2 Million. This is based on reported shares across multiple companies, which include Sarepta Therapeutics, Inc., Unity Biotechnology, Inc., Aptinyx Inc., and Editas Medicine, Inc..
SEC CIK
Gilmore Neil O'Neill's CIK is 0001742084
Past Insider Trading and Trends
2021 was Gilmore Neil O'Neill's most active year for acquiring shares with 5 total transactions. Gilmore Neil O'Neill's most active month to acquire stocks was the month of May. 2019 was Gilmore Neil O'Neill's most active year for disposing of shares, totalling 2 transactions. Gilmore Neil O'Neill's most active month to dispose stocks was the month of April. 2022 saw Gilmore Neil O'Neill paying a total of $0.00 for 1,101,864 shares, this is the most they've acquired in one year. In 2019 Gilmore Neil O'Neill cashed out on 16,630 shares for a total of $552,405.30, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $126.38
EVP, R&D & CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +102.89% | 14.48K |
$86.97 | -$45,572.28 | 28.55K |
Feb 28 - Mar 3
| |||
Form 4
| +106.61% | 15K |
—
|
—
| 29.07K |
Mar 3
| |||
Form 4
| +90.91% | 6.7K |
—
|
—
| 14.07K |
Feb 28
| |||
Form 4
|
∞
| 7.37K |
$119.31 | -$552,405.30 | 7.37K |
May 23 - May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Unity Biotechnology, Inc. (UBX) Snapshot price: $1.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aptinyx Inc. (APTX) Snapshot price: $0.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Editas Medicine, Inc. (EDIT) Snapshot price: $7.145
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.72% | -12.19K |
$5.50 | -$66,996.86 | 315.28K |
Scheduled
|
Jun 4
| ||
Form 4
| +151.57% | 197.3K |
$9.42 | -$732,884.17 | 327.47K |
Scheduled
|
Mar 2 - Mar 5
| ||
Form 4
| -4.75% | -6.49K |
$9.50 | -$61,637.76 | 130.17K |
Jun 5
| |||
Form 4
| +57.70% | 50K |
—
|
—
| 136.66K |
Mar 2
| |||
Form 4
|
∞
| 86.66K |
—
|
—
| 86.66K |
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||